Researchers are exploring the use of cell membrane-coated nanoparticles to target carcinogenic bacteria. The approach is part of a broader effort to understand the role of gut microbiota in cancer development and to develop new strategies for cancer therapy, including precision diagnosis and treatment. Various studies and reviews are examining the potential of biomimetic nanoparticles and other bioinspired platforms to modulate gut microbiota and combat cancer.